U.S. Supreme Court Denies Certiorari In FCA Public Disclosure Bar Dispute
WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 7 denied a petition for certiorari filed by pharmaceutical companies seeking review of the Ninth Circuit U.S. Court of Appeals’ ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article